TY  - JOUR
AU  - Girard-Alcindor, V
AU  - Stefan, I
AU  - de Oliveira Santos, F
AU  - Sorlin, O
AU  - Ackermann, D
AU  - Adsley, P
AU  - Angélique, J C
AU  - Assié, M
AU  - Assunção, M
AU  - Beaumel, D
AU  - Berthoumieux, E
AU  - Borcea, R
AU  - Cáceres, L
AU  - Čeliković, Igor T.
AU  - Ciemala, M
AU  - Chudoba, V
AU  - D’Agata, G
AU  - de Grancey, F
AU  - Dumitru, G
AU  - Flavigny, F
AU  - Fougères, C
AU  - Franchoo, S
AU  - Georgiadou, A
AU  - Goyal, N
AU  - Grévy, S
AU  - Guillot, J
AU  - Guimaraes, V
AU  - Hammache, F
AU  - Kamalou, O
AU  - Kiener, J
AU  - Koyama, S
AU  - Lalanne, L
AU  - Lapoux, V
AU  - Matea, I
AU  - Matta, A
AU  - Meyer, A
AU  - Michel, N
AU  - Morfouace, P
AU  - Mrazek, J
AU  - Negoita, F
AU  - Niikura, M
AU  - Pantelica, D
AU  - Perrot, L
AU  - Petrone, C
AU  - Piot, J
AU  - Portail, C
AU  - Roger, T
AU  - Rotaru, F
AU  - Sánchez Benítez, A M
AU  - de Séréville, N
AU  - Stanoiu, M
AU  - Stodel, C
AU  - Subotić, Krunoslav M.
AU  - Suzuki, D
AU  - Tatischeff, V
AU  - Thomas, J C
AU  - Ujić, Predrag
AU  - Verney, D
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/9152
AB  - The unbound proton-rich nuclei 16F and 15F are investigated experimentally and theoretically. Several experiments using the resonant elastic scattering method were performed at GANIL with radioactive beams to determine the properties of the low lying states of these nuclei. Strong asymmetry between 16F–16N and 15F–15C mirror nuclei is observed. The strength of the nucleon- nucleon effective interaction involving the loosely bound proton in the s1 / 2 orbit is significantly modified with respect to their mirror nuclei 16N and 15C. The reduction of the effective interaction is estimated by calculating the interaction energies with a schematic zero-range force. It is found that, after correcting for the effects due to changes in the radial distribution of the single-particle wave functions, the mirror symmetry of the n- p interaction is preserved between 16F and 16N, while a difference of 63% is measured between the p- p versus n- n interactions in the second excited state of 15F and 15C nuclei. Several explanations are proposed. © 2021, The Author(s), under exclusive licence to Società Italiana di Fisica and Springer-Verlag GmbH Germany, part of Springer Nature.
T2  - The European Physical Journal A
T1  - Probing nuclear forces beyond the nuclear drip line: the cases of 16F and 15F: a tribute to Mahir Hussein
VL  - 57
IS  - 3
SP  - 93
DO  - 10.1140/epja/s10050-021-00410-1
ER  - 

@article{
author = "Girard-Alcindor, V and Stefan, I and de Oliveira Santos, F and Sorlin, O and Ackermann, D and Adsley, P and Angélique, J C and Assié, M and Assunção, M and Beaumel, D and Berthoumieux, E and Borcea, R and Cáceres, L and Čeliković, Igor T. and Ciemala, M and Chudoba, V and D’Agata, G and de Grancey, F and Dumitru, G and Flavigny, F and Fougères, C and Franchoo, S and Georgiadou, A and Goyal, N and Grévy, S and Guillot, J and Guimaraes, V and Hammache, F and Kamalou, O and Kiener, J and Koyama, S and Lalanne, L and Lapoux, V and Matea, I and Matta, A and Meyer, A and Michel, N and Morfouace, P and Mrazek, J and Negoita, F and Niikura, M and Pantelica, D and Perrot, L and Petrone, C and Piot, J and Portail, C and Roger, T and Rotaru, F and Sánchez Benítez, A M and de Séréville, N and Stanoiu, M and Stodel, C and Subotić, Krunoslav M. and Suzuki, D and Tatischeff, V and Thomas, J C and Ujić, Predrag and Verney, D",
year = "2021",
abstract = "The unbound proton-rich nuclei 16F and 15F are investigated experimentally and theoretically. Several experiments using the resonant elastic scattering method were performed at GANIL with radioactive beams to determine the properties of the low lying states of these nuclei. Strong asymmetry between 16F–16N and 15F–15C mirror nuclei is observed. The strength of the nucleon- nucleon effective interaction involving the loosely bound proton in the s1 / 2 orbit is significantly modified with respect to their mirror nuclei 16N and 15C. The reduction of the effective interaction is estimated by calculating the interaction energies with a schematic zero-range force. It is found that, after correcting for the effects due to changes in the radial distribution of the single-particle wave functions, the mirror symmetry of the n- p interaction is preserved between 16F and 16N, while a difference of 63% is measured between the p- p versus n- n interactions in the second excited state of 15F and 15C nuclei. Several explanations are proposed. © 2021, The Author(s), under exclusive licence to Società Italiana di Fisica and Springer-Verlag GmbH Germany, part of Springer Nature.",
journal = "The European Physical Journal A",
title = "Probing nuclear forces beyond the nuclear drip line: the cases of 16F and 15F: a tribute to Mahir Hussein",
volume = "57",
number = "3",
pages = "93",
doi = "10.1140/epja/s10050-021-00410-1"
}

Girard-Alcindor, V., Stefan, I., de Oliveira Santos, F., Sorlin, O., Ackermann, D., Adsley, P., Angélique, J. C., Assié, M., Assunção, M., Beaumel, D., Berthoumieux, E., Borcea, R., Cáceres, L., Čeliković, I. T., Ciemala, M., Chudoba, V., D’Agata, G., de Grancey, F., Dumitru, G., Flavigny, F., Fougères, C., Franchoo, S., Georgiadou, A., Goyal, N., Grévy, S., Guillot, J., Guimaraes, V., Hammache, F., Kamalou, O., Kiener, J., Koyama, S., Lalanne, L., Lapoux, V., Matea, I., Matta, A., Meyer, A., Michel, N., Morfouace, P., Mrazek, J., Negoita, F., Niikura, M., Pantelica, D., Perrot, L., Petrone, C., Piot, J., Portail, C., Roger, T., Rotaru, F., Sánchez Benítez, A. M., de Séréville, N., Stanoiu, M., Stodel, C., Subotić, K. M., Suzuki, D., Tatischeff, V., Thomas, J. C., Ujić, P.,& Verney, D.. (2021). Probing nuclear forces beyond the nuclear drip line: the cases of 16F and 15F: a tribute to Mahir Hussein. in The European Physical Journal A, 57(3), 93.
https://doi.org/10.1140/epja/s10050-021-00410-1

Girard-Alcindor V, Stefan I, de Oliveira Santos F, Sorlin O, Ackermann D, Adsley P, Angélique JC, Assié M, Assunção M, Beaumel D, Berthoumieux E, Borcea R, Cáceres L, Čeliković IT, Ciemala M, Chudoba V, D’Agata G, de Grancey F, Dumitru G, Flavigny F, Fougères C, Franchoo S, Georgiadou A, Goyal N, Grévy S, Guillot J, Guimaraes V, Hammache F, Kamalou O, Kiener J, Koyama S, Lalanne L, Lapoux V, Matea I, Matta A, Meyer A, Michel N, Morfouace P, Mrazek J, Negoita F, Niikura M, Pantelica D, Perrot L, Petrone C, Piot J, Portail C, Roger T, Rotaru F, Sánchez Benítez AM, de Séréville N, Stanoiu M, Stodel C, Subotić KM, Suzuki D, Tatischeff V, Thomas JC, Ujić P, Verney D. Probing nuclear forces beyond the nuclear drip line: the cases of 16F and 15F: a tribute to Mahir Hussein. in The European Physical Journal A. 2021;57(3):93.
doi:10.1140/epja/s10050-021-00410-1 .

Girard-Alcindor, V, Stefan, I, de Oliveira Santos, F, Sorlin, O, Ackermann, D, Adsley, P, Angélique, J C, Assié, M, Assunção, M, Beaumel, D, Berthoumieux, E, Borcea, R, Cáceres, L, Čeliković, Igor T., Ciemala, M, Chudoba, V, D’Agata, G, de Grancey, F, Dumitru, G, Flavigny, F, Fougères, C, Franchoo, S, Georgiadou, A, Goyal, N, Grévy, S, Guillot, J, Guimaraes, V, Hammache, F, Kamalou, O, Kiener, J, Koyama, S, Lalanne, L, Lapoux, V, Matea, I, Matta, A, Meyer, A, Michel, N, Morfouace, P, Mrazek, J, Negoita, F, Niikura, M, Pantelica, D, Perrot, L, Petrone, C, Piot, J, Portail, C, Roger, T, Rotaru, F, Sánchez Benítez, A M, de Séréville, N, Stanoiu, M, Stodel, C, Subotić, Krunoslav M., Suzuki, D, Tatischeff, V, Thomas, J C, Ujić, Predrag, Verney, D, "Probing nuclear forces beyond the nuclear drip line: the cases of 16F and 15F: a tribute to Mahir Hussein" in The European Physical Journal A, 57, no. 3 (2021):93,
https://doi.org/10.1140/epja/s10050-021-00410-1 . .

TY  - JOUR
AU  - Herrick, Ariane L.
AU  - Pan, Xiaoyan
AU  - Peytrignet, Sebastien
AU  - Lunt, Mark
AU  - Hesselstrand, Roger
AU  - Mouthon, Luc
AU  - Silman, Alan
AU  - Brown, Edith
AU  - Czirjak, Laszlo
AU  - Distler, Joerg H. W.
AU  - Distler, Oliver
AU  - Fligelstone, Kim
AU  - Gregory, William J.
AU  - Ochiel, Rachel
AU  - Vonk, Madelon
AU  - Ancuta, Codrina
AU  - Ong, Voon H.
AU  - Farge, Dominique
AU  - Hudson, Marie
AU  - Matucci-Cerinic, Marco
AU  - Balbir-Gurman, Alexandra
AU  - Midtvedt, Oyvind
AU  - Jordan, Alison C.
AU  - Jobanputra, Paresh
AU  - Stevens, Wendy
AU  - Moinzadeh, Pia
AU  - Hall, Frances C.
AU  - Agard, Christian
AU  - Anderson, Marina E.
AU  - Diot, Elisabeth
AU  - Madhok, Rajan
AU  - Akil, Mohammed
AU  - Buch, Maya H.
AU  - Chung, Lorinda
AU  - Damjanov, Nemanja
AU  - Gunawardena, Harsha
AU  - Lanyon, Peter
AU  - Ahmad, Yasmeen
AU  - Chakravarty, Kuntal
AU  - Jacobsen, Soren
AU  - MacGregor, Alexander J.
AU  - McHugh, Neil
AU  - Mueller-Ladner, Ulf
AU  - Riemekasten, Gabriela
AU  - Becker, Michael
AU  - Roddy, Janet
AU  - Carreira, Patricia E.
AU  - Fauchais, Anne Laure
AU  - Hachulla, Eric
AU  - Hamilton, Jennifer
AU  - Inanc, Murat
AU  - McLaren, John S.
AU  - van Laar, Jacob M.
AU  - Pathare, Sanjay
AU  - Proudman, Susannah
AU  - Rudin, Anna
AU  - Sahhar, Joanne
AU  - Coppere, Brigitte
AU  - Serratrice, Christine
AU  - Sheeran, Tom
AU  - Veale, Douglas J.
AU  - Grange, Claire
AU  - Trad, Georges-Selim
AU  - Denton, Christopher P.
PY  - 2017
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/1599
AB  - Objectives The rarity of early diffuse cutaneous systemic sclerosis (dcSSc) makes randomised controlled trials very difficult. We aimed to use an observational approach to compare effectiveness of currently used treatment approaches. Methods This was a prospective, observational cohort study of early dcSSc (within three years of onset of skin thickening). Clinicians selected one of four protocols for each patient: methotrexate, mycophenolate mofetil (MMF), cyclophosphamide or no immunosuppressant. Patients were assessed three-monthly for up to 24 months. The primary outcome was the change in modified Rodnan skin score (mRSS). Confounding by indication at baseline was accounted for using inverse probability of treatment (IPT) weights. As a secondary outcome, an IPT-weighted Cox model was used to test for differences in survival. Results Of 326 patients recruited from 50 centres, 65 were prescribed methotrexate, 118 MMF, 87 cyclophosphamide and 56 no immunosuppressant. 276 (84.7%) patients completed 12 and 234 (71.7%) 24 months follow-up (or reached last visit date). There were statistically significant reductions in mRSS at 12 months in all groups: -4.0 (-5.2 to -2.7) units for methotrexate, -4.1 (-5.3 to -2.9) for MMF, -3.3 (-4.9 to -1.7) for cyclophosphamide and -2.2 (-4.0 to -0.3) for no immunosuppressant (p value for between-group differences=0.346). There were no statistically significant differences in survival between protocols before (p=0.389) or after weighting (p=0.440), but survival was poorest in the no immunosuppressant group (84.0%) at 24 months. Conclusions These findings may support using immunosuppressants for early dcSSc but suggest that overall benefit is modest over 12 months and that better treatments are needed.
T2  - Annals of the Rheumatic Diseases
T1  - Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
VL  - 76
IS  - 7
SP  - 1207
EP  - 1218
DO  - 10.1136/annrheumdis-2016-210503
ER  - 

@article{
author = "Herrick, Ariane L. and Pan, Xiaoyan and Peytrignet, Sebastien and Lunt, Mark and Hesselstrand, Roger and Mouthon, Luc and Silman, Alan and Brown, Edith and Czirjak, Laszlo and Distler, Joerg H. W. and Distler, Oliver and Fligelstone, Kim and Gregory, William J. and Ochiel, Rachel and Vonk, Madelon and Ancuta, Codrina and Ong, Voon H. and Farge, Dominique and Hudson, Marie and Matucci-Cerinic, Marco and Balbir-Gurman, Alexandra and Midtvedt, Oyvind and Jordan, Alison C. and Jobanputra, Paresh and Stevens, Wendy and Moinzadeh, Pia and Hall, Frances C. and Agard, Christian and Anderson, Marina E. and Diot, Elisabeth and Madhok, Rajan and Akil, Mohammed and Buch, Maya H. and Chung, Lorinda and Damjanov, Nemanja and Gunawardena, Harsha and Lanyon, Peter and Ahmad, Yasmeen and Chakravarty, Kuntal and Jacobsen, Soren and MacGregor, Alexander J. and McHugh, Neil and Mueller-Ladner, Ulf and Riemekasten, Gabriela and Becker, Michael and Roddy, Janet and Carreira, Patricia E. and Fauchais, Anne Laure and Hachulla, Eric and Hamilton, Jennifer and Inanc, Murat and McLaren, John S. and van Laar, Jacob M. and Pathare, Sanjay and Proudman, Susannah and Rudin, Anna and Sahhar, Joanne and Coppere, Brigitte and Serratrice, Christine and Sheeran, Tom and Veale, Douglas J. and Grange, Claire and Trad, Georges-Selim and Denton, Christopher P.",
year = "2017",
abstract = "Objectives The rarity of early diffuse cutaneous systemic sclerosis (dcSSc) makes randomised controlled trials very difficult. We aimed to use an observational approach to compare effectiveness of currently used treatment approaches. Methods This was a prospective, observational cohort study of early dcSSc (within three years of onset of skin thickening). Clinicians selected one of four protocols for each patient: methotrexate, mycophenolate mofetil (MMF), cyclophosphamide or no immunosuppressant. Patients were assessed three-monthly for up to 24 months. The primary outcome was the change in modified Rodnan skin score (mRSS). Confounding by indication at baseline was accounted for using inverse probability of treatment (IPT) weights. As a secondary outcome, an IPT-weighted Cox model was used to test for differences in survival. Results Of 326 patients recruited from 50 centres, 65 were prescribed methotrexate, 118 MMF, 87 cyclophosphamide and 56 no immunosuppressant. 276 (84.7%) patients completed 12 and 234 (71.7%) 24 months follow-up (or reached last visit date). There were statistically significant reductions in mRSS at 12 months in all groups: -4.0 (-5.2 to -2.7) units for methotrexate, -4.1 (-5.3 to -2.9) for MMF, -3.3 (-4.9 to -1.7) for cyclophosphamide and -2.2 (-4.0 to -0.3) for no immunosuppressant (p value for between-group differences=0.346). There were no statistically significant differences in survival between protocols before (p=0.389) or after weighting (p=0.440), but survival was poorest in the no immunosuppressant group (84.0%) at 24 months. Conclusions These findings may support using immunosuppressants for early dcSSc but suggest that overall benefit is modest over 12 months and that better treatments are needed.",
journal = "Annals of the Rheumatic Diseases",
title = "Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)",
volume = "76",
number = "7",
pages = "1207-1218",
doi = "10.1136/annrheumdis-2016-210503"
}

Herrick, A. L., Pan, X., Peytrignet, S., Lunt, M., Hesselstrand, R., Mouthon, L., Silman, A., Brown, E., Czirjak, L., Distler, J. H. W., Distler, O., Fligelstone, K., Gregory, W. J., Ochiel, R., Vonk, M., Ancuta, C., Ong, V. H., Farge, D., Hudson, M., Matucci-Cerinic, M., Balbir-Gurman, A., Midtvedt, O., Jordan, A. C., Jobanputra, P., Stevens, W., Moinzadeh, P., Hall, F. C., Agard, C., Anderson, M. E., Diot, E., Madhok, R., Akil, M., Buch, M. H., Chung, L., Damjanov, N., Gunawardena, H., Lanyon, P., Ahmad, Y., Chakravarty, K., Jacobsen, S., MacGregor, A. J., McHugh, N., Mueller-Ladner, U., Riemekasten, G., Becker, M., Roddy, J., Carreira, P. E., Fauchais, A. L., Hachulla, E., Hamilton, J., Inanc, M., McLaren, J. S., van Laar, J. M., Pathare, S., Proudman, S., Rudin, A., Sahhar, J., Coppere, B., Serratrice, C., Sheeran, T., Veale, D. J., Grange, C., Trad, G.,& Denton, C. P.. (2017). Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). in Annals of the Rheumatic Diseases, 76(7), 1207-1218.
https://doi.org/10.1136/annrheumdis-2016-210503

Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirjak L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt O, Jordan AC, Jobanputra P, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Mueller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanc M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad G, Denton CP. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). in Annals of the Rheumatic Diseases. 2017;76(7):1207-1218.
doi:10.1136/annrheumdis-2016-210503 .

Herrick, Ariane L., Pan, Xiaoyan, Peytrignet, Sebastien, Lunt, Mark, Hesselstrand, Roger, Mouthon, Luc, Silman, Alan, Brown, Edith, Czirjak, Laszlo, Distler, Joerg H. W., Distler, Oliver, Fligelstone, Kim, Gregory, William J., Ochiel, Rachel, Vonk, Madelon, Ancuta, Codrina, Ong, Voon H., Farge, Dominique, Hudson, Marie, Matucci-Cerinic, Marco, Balbir-Gurman, Alexandra, Midtvedt, Oyvind, Jordan, Alison C., Jobanputra, Paresh, Stevens, Wendy, Moinzadeh, Pia, Hall, Frances C., Agard, Christian, Anderson, Marina E., Diot, Elisabeth, Madhok, Rajan, Akil, Mohammed, Buch, Maya H., Chung, Lorinda, Damjanov, Nemanja, Gunawardena, Harsha, Lanyon, Peter, Ahmad, Yasmeen, Chakravarty, Kuntal, Jacobsen, Soren, MacGregor, Alexander J., McHugh, Neil, Mueller-Ladner, Ulf, Riemekasten, Gabriela, Becker, Michael, Roddy, Janet, Carreira, Patricia E., Fauchais, Anne Laure, Hachulla, Eric, Hamilton, Jennifer, Inanc, Murat, McLaren, John S., van Laar, Jacob M., Pathare, Sanjay, Proudman, Susannah, Rudin, Anna, Sahhar, Joanne, Coppere, Brigitte, Serratrice, Christine, Sheeran, Tom, Veale, Douglas J., Grange, Claire, Trad, Georges-Selim, Denton, Christopher P., "Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)" in Annals of the Rheumatic Diseases, 76, no. 7 (2017):1207-1218,
https://doi.org/10.1136/annrheumdis-2016-210503 . .